Cary Street Partners Investment Advisory LLC Horizon Therapeutics Public LTD CO Transaction History

Cary Street Partners Investment Advisory LLC

  • $2.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$107.32 - $113.5 $856,628 - $905,957
-7,982 Reduced 97.76%
183 $19,000
Q4 2022

Feb 14, 2023
SELL
$62.39 - $113.8 $49,225 - $89,788
-789 Reduced 8.81%
8,165 $929,000
Q3 2022

Nov 14, 2022
SELL
$58.92 - $84.67 $7,188 - $10,329
-122 Reduced 1.34%
8,954 $554,000
Q2 2022

Aug 15, 2022
BUY
$79.4 - $116.36 $720,634 - $1.06 Million
9,076 New
9,076 $724,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email